EW
Edwards LifesciencesCNYSE / Health Care Equipment & Services
Last Price
At close
2026-07-18
Current thesis
Durable share gains in transcatheter and surgical valve franchises plus margin expansion from operational leverage and successful new-device adoption push the stock toward the high end of analyst targets within 12 months.
Posture
Mixed
Lead driver
Value
What changed
Next scheduled catalyst: earnings 2026-07-23 · AMC.
What can break
Procedure volume slowdown or macro-driven elective surgery declines
Momentum
39
Value
54
Sentiment
60
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $95.00 · Bull $110.00 · Bear $76.80
Earnings
2026-07-23 · AMC
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-02-12 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-07-18
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $100.03
Why
Momentum39 · Δ7d -15.0
Value54 · Δ7d +0.5
Sentiment60 · Δ7d +4.1
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Value · See fundamentals
Momentum
39
26% active weight
Current posture
7d trendSoftening
Δ7d
-15.0
Δ21d
-23.6
Value
54
39% active weight
Current posture
7d trendFlat
Δ7d
+0.5
Δ21d
+0.8
Sentiment
60
34% active weight
Current posture
7d trendImproving
Δ7d
+4.1
Δ21d
+4.2
Why this grade
Composite grade C. Momentum 39.0 / Value 53.8 / Sentiment 60.0
Fundamentals (TTM)As of 2026-07-17
Fundamentals (TTM)
As of 2026-07-17
Market Cap
$49.36B
Beta
0.94
Shares Out
575.8M
P/E (TTM)
36.9
P/S (TTM)
8.30
P/FCF (TTM)
61.09
Rev YoY
+16.7%
EPS YoY
+5.5%
Gross Margin
+78.0%
Op Margin
+23.4%
Net Debt
-$3.52B
Current Ratio
4.42
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology